Compare CLST & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLST | MYO |
|---|---|---|
| Founded | 1922 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.8M | 63.8M |
| IPO Year | 2021 | 2017 |
| Metric | CLST | MYO |
|---|---|---|
| Price | $16.75 | $1.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $4.64 |
| AVG Volume (30 Days) | 2.2K | ★ 311.2K |
| Earning Date | 10-26-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 171.79 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | N/A | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $11.43 |
| Revenue Next Year | N/A | $12.29 |
| P/E Ratio | $57.50 | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $13.24 | $0.61 |
| 52 Week High | $20.50 | $1.89 |
| Indicator | CLST | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 38.36 |
| Support Level | $16.28 | $1.18 |
| Resistance Level | $17.27 | $1.75 |
| Average True Range (ATR) | 0.24 | 0.12 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 44.39 | 12.28 |
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It operates in one reportable segment, which generates income principally from interest on loans and investment securities, as well as from fees charged in connection with various loan and deposit services.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.